The AI Race Hits the Brakes: Why Altman, Amodei and Musk Want to Slow Down

AI development to slowdown

Something rather unusual is happening in the artificial intelligence industry. Three of its most prominent and outspoken figures — Anthropic CEO Dario Amodei, OpenAI CEO Sam Altman and xAI boss Elon Musk — are now reportedly broadly agreeing on something: the development of increasingly powerful AI may need to slow down.

That is a remarkable change in tone for an industry built around moving faster

Amodei has gone furthest, arguing that frontier AI companies should deliberately pace the development of their most capable systems.

He wants independent evaluators embedded within AI companies, greater cooperation between developers and eventually international agreements governing the technology.

So why now?

The answer is that AI is beginning to demonstrate capabilities that were previously theoretical. Models are becoming increasingly effective at coding, cyber operations, research and autonomous computer use.

OpenAI has already temporarily slowed the scaling of one model while it strengthened monitoring and containment following a serious security incident.

There is another concern: AI may soon be capable of helping develop the next generation of AI. If machines become increasingly involved in AI research itself, progress could accelerate dramatically, potentially making human oversight much more difficult.

But will the industry actually slow down?

That is the big question. There is an enormous commercial incentive to keep moving. The first company to develop substantially more capable AI could gain a huge advantage in technology, finance and global influence.

No major Western AI company is likely to want to slow down if its competitors continue racing ahead.

And then there is China

A voluntary slowdown involving American companies would be difficult if Chinese developers continued accelerating.

Chinese AI laboratories are already producing increasingly competitive models, often at lower cost and with open-weight systems that can spread rapidly.

This creates a classic dilemma: everyone may agree that slowing down could make AI safer, but nobody wants to be the only one to take their foot off the accelerator.

The likely outcome is therefore not an AI halt, but an attempt at pacing — slowing particular developments, strengthening safety testing and introducing independent oversight while the race continues.

The irony is striking. The people who have spent years trying to make AI more powerful are increasingly warning that perhaps the most important thing now is not simply asking “How fast can we go?”

It is asking “Where we are going?”

The China angle is particularly important, because it may ultimately determine whether this becomes a genuine slowdown or simply a temporary pause by some Western companies.

Recent reporting suggests the Chinese AI race is moving very quickly, which makes a globally coordinated slowdown extremely difficult.

OpenAI Reportedly Shelves IPO as AI Concerns Grow

OpenAI IPO

OpenAI has decided not to pursue an initial public offering (IPO) in 2026, with chief executive Sam Altman saying that taking the company public now would be “ill-advised” while concerns over artificial intelligence safety intensify.

Signicant decision

The decision represents a significant change for financial markets, which had been anticipating one of the world’s biggest technology listings.

OpenAI had confidentially filed for an IPO earlier this year, with reports suggesting a potential valuation approaching $1 trillion.

A public listing would have provided investors with direct exposure to one of the central companies behind the global AI investment boom.

Wider consequences

The decision could therefore have wider consequences. Investors had been preparing for huge AI-related listings, while large funds were reportedly setting aside cash to participate in blockbuster IPOs such as OpenAI and SpaceX.

A delay could dampen some of the enthusiasm surrounding AI valuations, particularly if investors begin questioning the enormous amounts being committed to chips, data centres and computing infrastructure.

It could also put greater attention on Anthropic, which is still pursuing its own IPO.

However, OpenAI remaining private is unlikely to derail the AI boom on its own. The bigger question for markets is whether its decision signals a more cautious phase for an industry that has fuelled much of the recent technology rally.

Anthropic Reportedly Blocked AI-Assisted Weapon Research

Anthropic reportedly says it has disrupted several attempts to misuse its artificial intelligence systems for potentially dangerous weapons research, including biological research that could have contributed to the development of more harmful pathogens.

Threat

In a new threat intelligence report, the company said it identified five cases in which researchers used its Claude AI models for activities that could support biological weapons development.

Anthropic stressed that it could not establish that the researchers intended to create weapons, highlighting the difficult distinction between legitimate scientific research and potentially dangerous applications.

Concerns

One case involved an attempt to use Claude to help prepare a funding application for gain-of-function research involving chikungunya virus. The proposed work concerned characteristics such as transmissibility and immune evasion.

Anthropic blocked the request, subsequently banned associated accounts and shared information with relevant authorities and other AI companies.

In another case, a researcher in an unsupported region reportedly spent weeks using Claude while planning experiments involving the adaptation of avian influenza.

Safeguards

Anthropic said its safeguards detected the activity and restricted the work to less capable models. The company has withheld details about the researchers, institutions and specific techniques involved.

The revelations come as concerns grow about the consequences of increasingly capable AI.

Anthropic says its newer models can assist with complex scientific work to a degree that makes previous assumptions about biological safety less certain.

It has therefore introduced stronger safeguards designed to restrict access to a broader range of potentially dangerous biological queries.

Weapons

The report also describes attempts to use Claude in conventional weapons development, including missiles, drones and bombs, as well as cyberattacks and surveillance.

Dilemma

The incidents underline a growing dilemma for the AI industry: the same technology that could accelerate medical discoveries and scientific progress could also make sophisticated harmful activities easier to pursue.

Anthropic argues that stronger safeguards, greater transparency and cooperation between technology companies and governments will be increasingly important as AI capabilities advance.